Perspectives in Peptide-Based Vaccination Strategies for Syndrome Coronavirus 2 Pandemic
Pharmacology
[키워드] acute respiratory distress
acute respiratory syndrome
approach
approved
breath
caused
characterized
clinical trials
Coronaviridae
coronavirus
coronavirus 2
Coronavirus infection
COVID-19
COVID-19 infection
COVID-19 pandemic
demonstrated
develop
drug candidate
Efficacy
effort
enveloped RNA virus
Epidemic
Epidemics
epitope
expected
feature
Health
health emergency
high mortality rate
highlight
Host immune response
host-pathogen interaction
Human
human cell
human CoV infection
human immune response
immunogenic
In vitro studies
induce
infect
Infection
Interaction
Laboratory
majority
mammals
membrane
MERS-CoV
Middle East
Mild
molecular basis
Nucleocapsid proteins
other coronaviruses
peptide
peptide on market
peptide-based
peptide-based vaccine
Region
Research
respiratory
respiratory tract infection
Safe
SARS-CoV
SARS-CoV-2
severe pneumonia
shown
specificity
Spread
Strategy
syndrome
targets
therapeutic strategy
Treatment
unique
Vaccine
Vaccine development
viral pathogen
virus
World Health Organization
Wuhan, China
[DOI] 10.3389/fphar.2020.578382 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2020.578382 PMC 바로가기 [Article Type] Pharmacology